Advocacy intelligence hub — real-time data for patient organizations
Cytalux: FDA approved
As an adjunct for intraoperative identification of malignant lesions in adult patients with ovarian cancer
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Cytalux
On Target Laboratories, LLC